iRhythm Technologies's revenue for the
three
months ended in Dec. 2024 was $164.3 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $591.8 Mil.
iRhythm Technologies's Revenue per Share for the
three
months ended in Dec. 2024 was $5.24.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $18.97.
During the past 12 months, the average Revenue per Share Growth Rate of iRhythm Technologies was 17.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 19.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 18.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 23.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 11 years, iRhythm Technologies's highest 3-Year average Revenue per Share Growth Rate was 43.80% per year. The lowest was -11.20% per year. And the median was 20.60% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's Revenue
For the Medical Devices subindustry, iRhythm Technologies's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's Revenue distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $591.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
iRhythm Technologies Revenue Related Terms
Thank you for viewing the detailed overview of iRhythm Technologies's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 